SHH-positive livers from NASH patients express higher levels of fibrogenic and immunomodulatory genes compared to SHH-negative NASH liver samples, whose transcriptomes resemble steatotic, non-NASH livers (209). The gene discussed is SHH; the disease is metabolic dysfunction-associated steatohepatitis.